China approves first biosimilar cancer drug
Businessam StaffFebruary 27, 2019
China’s National Medical Products Administration (NMPA) says it has approved the country’s very first biosimilar, a copy of Roche’s
0Deal
Novartis pays $150m to license Akcea-Ionis cardiac disease drug
Businessam StaffFebruary 27, 2019
Novartis has taken up its option to license antisense oligonucleotide TQJ230, triggering a $150 million payout that Akcea Therapeutics
UK deeply disappointed by Honda’s decision to close plant
Businessam StaffFebruary 19, 2019
Britain on Tuesday said it was deeply disappointed by Honda’s decision to close its only British car plant. “The UK is one of the
Honda to close UK car plant with the loss of 3,500 job
Businessam StaffFebruary 18, 2019
Japanese carmaker Honda is set to announce the closure of its only British car plant in 2022 with the loss of 3,500 jobs, a lawmaker
Germany narrowly escapes recession after flat growth in the fourth quarter
Businessam StaffFebruary 14, 2019
Germany has narrowly avoided a technical recession after it posted flat growth in the fourth quarter, raising concerns that
U.S. group says Trump trade tariffs cost businesses $2.7 billion in November
Businessam StaffFebruary 14, 2019
U.S. businesses paid an additional $2.7 billion in tariffs in November 2018, according to data from a coalition of U.S. business
Top U.S. officials arrive in China for trade talks as deadline looms
Businessam StaffFebruary 12, 2019
Top U.S. officials arrived in the Chinese capital on Tuesday ahead of high-level trade talks as the world’s two largest economies
Bank of England sees weakest UK outlook since 2009 on Brexit, global slowdown
Businessam StaffFebruary 7, 2019
The Bank of England said Britain faced its weakest economic growth in 10 years in 2019, blaming mounting Brexit uncertainty and the
EU slashes euro zone growth outlook, expects inflation to slow
Businessam StaffFebruary 7, 2019
The European Commission sharply cut on Thursday its forecasts for euro zone economic growth this year and next because it expects the
0Deal
EU blocks Alstom-Siemens rail merger due to ‘serious competition concerns’
Businessam StaffFebruary 6, 2019
The European Union blocked the rail deal between Alstom and Siemens on Wednesday, citing competition concerns. The merger proposal